Literature DB >> 1384487

Interferon-gamma inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generation.

Y Nunokawa1, S Tanaka.   

Abstract

Interferon (IFN)-gamma inhibited the proliferation of rat vascular smooth muscle cells (VSMC) and increased the cyclic GMP (cGMP) concentration in the cells. The dose dependencies of the two effects were similar (IC50 = 4 U/ml for the anti-proliferation and EC50 = 3 U/ml for cGMP formation) and the effect of IFN-gamma was enhanced by tumor necrosis factor-alpha treatment. Furthermore, NG-nitro-L-arginine, a nitric oxide (NO) synthase inhibitor, inhibited both activities induced by IFN-gamma. These findings show that the anti-proliferation and cGMP formation are closely related and that IFN-gamma inhibits the proliferation of rat VSMC by generation of NO through the induction of an NO synthase.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384487     DOI: 10.1016/0006-291x(92)92400-r

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Parallel regulation of arginine transport and nitric oxide synthesis by angiotensin II in vascular smooth muscle cells role of protein kinase C.

Authors:  M Rivera-Correa; P I Altieri; N Escobales
Journal:  Amino Acids       Date:  1996-06       Impact factor: 3.520

2.  MRI assessment of coronary microvascular endothelial nitric oxide synthase function using myocardial T1 mapping.

Authors:  Sophia X Cui; Frederick H Epstein
Journal:  Magn Reson Med       Date:  2017-08-07       Impact factor: 4.668

Review 3.  Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling.

Authors:  Ulrich Förstermann; Huige Li
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 4.  Nitric oxide synthases: regulation and function.

Authors:  Ulrich Förstermann; William C Sessa
Journal:  Eur Heart J       Date:  2011-09-01       Impact factor: 29.983

5.  MMP-9-Dependent Serum-Borne Bioactivity Caused by Multiwalled Carbon Nanotube Exposure Induces Vascular Dysfunction via the CD36 Scavenger Receptor.

Authors:  Mario Aragon; Aaron Erdely; Lindsey Bishop; Rebecca Salmen; John Weaver; Jim Liu; Pamela Hall; Tracy Eye; Vamsi Kodali; Patti Zeidler-Erdely; Jillian E Stafflinger; Andrew K Ottens; Matthew J Campen
Journal:  Toxicol Sci       Date:  2016-01-21       Impact factor: 4.849

6.  An antimelanoma immunotoxin containing recombinant human tumor necrosis factor: tissue disposition, pharmacokinetic, and therapeutic studies in xenograft models.

Authors:  M G Rosenblum; L Cheung; K Mujoo; J L Murray
Journal:  Cancer Immunol Immunother       Date:  1995-05       Impact factor: 6.968

7.  Transforming growth factor-beta 1 (TGF-beta1)-mediated inhibition of glial cell proliferation and down-regulation of intercellular adhesion molecule-1 (ICAM-1) are interrupted by interferon-gamma (IFN-gamma).

Authors:  B G Xiao; G X Zhang; C G Ma; H Link
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

8.  Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility.

Authors:  D C Rockey; J J Chung
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

Review 9.  Nitric oxide and endothelin in pathophysiological settings.

Authors:  T E Hunley; S Iwasaki; T Homma; V Kon
Journal:  Pediatr Nephrol       Date:  1995-04       Impact factor: 3.714

10.  Nitric oxide deficiency in pulmonary hypertension: Pathobiology and implications for therapy.

Authors:  Adriano R Tonelli; Sarah Haserodt; Metin Aytekin; Raed A Dweik
Journal:  Pulm Circ       Date:  2013-01       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.